We are live on
!
Find out more
RIM
RS Investment Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
3.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.36%
1 Year Est. Return
+3.24%
3 Year Est. Return
+50.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.73B
AUM Growth
-$385M
(-3.8%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
14.92%
Holding
438
New
62
Increased
134
Reduced
162
Closed
56
Top Buys
| 1 |
Kirby Corp
KEX
|
+$55M |
| 2 |
Integra LifeSciences
IART
|
+$51.1M |
| 3 |
LSXMK
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
|
+$45.4M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
+$43.4M |
| 5 |
Ingevity
NGVT
|
+$39.8M |
Top Sells
| 1 |
Myriad Genetics
MYGN
|
+$81.5M |
| 2 |
Steris
STE
|
+$57.7M |
| 3 |
Red Robin
RRGB
|
+$56.8M |
| 4 |
Dollar General
DG
|
+$52.6M |
| 5 |
Zebra Technologies
ZBRA
|
+$48.1M |
Sector Composition
| 1 | Technology | 17.3% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 14.01% |
| 4 | Consumer Discretionary | 13.08% |
| 5 | Industrials | 12.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
United Natural Foods
UNFI
$3.04B
| $13M | 0.13% |
278,335
-647,401
| -70% | -$24.9M |
|
|
KNL
227
DELISTED
Knoll, Inc.
KNL
| $13M | 0.13% |
534,937
-314,481
| -37% | -$7.38M |
|
|
SLCA
228
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $12.8M | 0.13% |
+370,210
| New | +$10.3M |
|
|
INVX
229
Innovex International
INVX
$1.8B
| $12.6M | 0.13% |
+214,920
| New | +$13M |
|
|
HAR
230
DELISTED
Harman International Industries
HAR
| $12.5M | 0.13% |
+174,474
| New | +$13.6M |
|
231
PepsiCo
PEP
$190B
| $11.8M | 0.12% |
+111,272
| New | +$11.5M |
|
232
Goldman Sachs
GS
$323B
| $11.4M | 0.12% |
76,778
+75,221
| +4,831% | +$11.7M |
|
233
Helen of Troy
HELE
$668M
| $11M | 0.11% |
+107,440
| New | +$10.8M |
|
|
RXDX
234
DELISTED
Ignyta, Inc.
RXDX
| $11M | 0.11% |
2,032,793
+338,794
| +20% | +$2.25M |
|
235
Alibaba
BABA
$282B
| $11M | 0.11% |
137,864
-19,394
| -12% | -$1.52M |
|
|
CRZO
236
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $10.5M | 0.11% |
292,399
-41,330
| -12% | -$1.48M |
|
|
IMDZ
237
DELISTED
Immune Design Corp.
IMDZ
| $10M | 0.1% |
1,227,595
+38,123
| +3% | +$475K |
|
238
Eastman Chemical
EMN
$7.91B
| $10M | 0.1% |
147,245
-23,634
| -14% | -$1.74M |
|
239
Tractor Supply
TSCO
$16.3B
| $9.19M | 0.09% |
504,100
-34,600
| -6% | -$643K |
|
240
Madison Square Garden
MSGS
$9.33B
| $9.1M | 0.09% |
73,923
-61,594
| -45% | -$7.23M |
|
241
Edwards Lifesciences
EW
$50.6B
| $9.08M | 0.09% |
273,270
-273,255
| -50% | -$9.35M |
|
|
PGND
242
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $8.81M | 0.09% |
+224,006
| New | +$7.5M |
|
|
PX
243
DELISTED
Praxair Inc
PX
| $8.78M | 0.09% |
78,154
+630
| +0.8% | +$71.5K |
|
244
Salesforce
CRM
$141B
| $8.73M | 0.09% |
109,980
+7,680
| +8% | +$603K |
|
245
Vornado Realty Trust
VNO
$7.67B
| $8.52M | 0.09% |
+105,306
| New | +$8.16M |
|
246
Extra Space Storage
EXR
$31.8B
| $8.4M | 0.09% |
90,790
+18,360
| +25% | +$1.66M |
|
|
CYAD
247
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| $8.18M | 0.08% |
327,363
-2,843
| -0.9% | -$135K |
|
248
Aptiv
APTV
$12.5B
| $7.93M | 0.08% |
126,765
+12,903
| +11% | +$902K |
|
|
GG
249
DELISTED
Goldcorp Inc
GG
| $7.69M | 0.08% |
401,880
+78
| +0% | +$1.38K |
|
250
Intuitive Surgical
ISRG
$142B
| $7.06M | 0.07% |
+96,120
| New | +$6.76M |
|
Similar funds
SG
KGI
VAM
FBNAT
CPS
LH
CPM
VFS
RS Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, RS Investment Management held 438 positions worth $9.73B, down 3.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RS Investment Management withdrew a net $739M in Q2 2016, closing 56 positions and reducing 162 holdings. Its most notable exit was Myriad Genetics, an estimated $81.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, RS Investment Management opened a new position in Kirby Corp worth $52.4M.
- RS Investment Management's largest Q2 2016 buy was Kirby Corp: 839,753 shares worth $52.4M.
- RS Investment Management added most to Allergan plc in Q2 2016, an estimated $36.7M increase.
- RS Investment Management's biggest Q2 2016 reduction was Steris, cutting an estimated $57.7M.
- RS Investment Management fully exited Myriad Genetics in Q2 2016, selling an estimated $81.5M.
- RS Investment Management's ten largest holdings make up 15% of its $9.73B portfolio in Q2 2016.
- RS Investment Management opened 62 new positions and closed 56 in Q2 2016.
- RS Investment Management's portfolio value fell 3.8% quarter-over-quarter to $9.73B.
Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.